Biomimetic glucose‑deprivation nanomedicine inducing ferroptosis and disulfidptosis for postoperative glioblastoma therapy

Glioblastoma (GBM) is the most aggressive primary brain tumor, with inevitable recurrence after surgery due to infiltrative growth and an immunosuppressive microenvironment. Current therapies remain inadequate, highlighting the need for strategies that eradicate residual cells and reprogram immunity. Our preliminary analysis revealed that GLUT1 is markedly upregulated in recurrent postoperative GBM, reflecting heightened glucose demand. Based on this, we developed a biomimetic nanomedicine (FePG@CM-ANG) composed of iron ions, the GLUT1 inhibitor phloretin, and glucose oxidase (GOx), cloaked with neutrophil membranes and modified with angiopep-2 peptides for enhanced blood-brain barrier penetration and postoperative targeting. This system induces glucose deprivation, coordinating disulfidptosis via cystine accumulation and ferroptosis through disruption of the SLC7A11/GSH/GPX4 axis, while iron-mediated Fenton reactions amplify oxidative stress. The resulting immunogenic cell death promotes dendritic cell maturation, cytotoxic T-cell infiltration, and macrophage polarization. In vitro and in vivo studies confirmed potent inhibition of GBM proliferation, migration, and recurrence, accompanied by antitumor immune activation and extended survival. These findings highlight FePG@CM-ANG as a promising postoperative GBM therapy that synergistically couples metabolic reprogramming with immune modulation for enhanced tumor suppression.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-17
DOI
https://doi.org/10.1186/s12951-026-05272-7
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biomimetic glucose‑deprivation nanomedicine inducing ferroptosis and disulfidptosis for postoperative glioblastoma therapy

Hai Huang, Xinyan Hao, Tianjiao Geng, Tiantian Tang et al.
5 links
Journal of Nanobiotechnology
Nanoplatforms for cancer theranostics
article

Biomimetic glucose‑deprivation nanomedicine inducing ferroptosis and disulfidptosis for postoperative glioblastoma therapy

Hai Huang, Xinyan Hao, Tianjiao Geng, Tiantian Tang, Dehua Liao, Ming Wang, Da-Xiong Xiang, Pengcheng Sun, Mengen Guo, Xinying Liu, Muyan Li, Junyong Wu
article en

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor, with inevitable recurrence after surgery due to infiltrative growth and an immunosuppressive microenvironment. Current therapies remain inadequate, highlighting the need for strategies that eradicate residual cells and reprogram immunity. Our preliminary analysis revealed that GLUT1 is markedly upregulated in recurrent postoperative GBM, reflecting heightened glucose demand. Based on this, we developed a biomimetic nanomedicine (FePG@CM-ANG) composed of iron ions, the GLUT1 inhibitor phloretin, and glucose oxidase (GOx), cloaked with neutrophil membranes and modified with angiopep-2 peptides for enhanced blood-brain barrier penetration and postoperative targeting. This system induces glucose deprivation, coordinating disulfidptosis via cystine accumulation and ferroptosis through disruption of the SLC7A11/GSH/GPX4 axis, while iron-mediated Fenton reactions amplify oxidative stress. The resulting immunogenic cell death promotes dendritic cell maturation, cytotoxic T-cell infiltration, and macrophage polarization. In vitro and in vivo studies confirmed potent inhibition of GBM proliferation, migration, and recurrence, accompanied by antitumor immune activation and extended survival. These findings highlight FePG@CM-ANG as a promising postoperative GBM therapy that synergistically couples metabolic reprogramming with immune modulation for enhanced tumor suppression.

Journal of Nanobiotechnology
Central South University (CN), Shanghai Jiao Tong University (CN), Renji Hospital (CN), Hunan Cancer Hospital (CN), Second Xiangya Hospital of Central South University (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation
Good health and well-being
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon